These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33289416)

  • 1. Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review.
    Claessen BE; Guedeney P; Gibson CM; Angiolillo DJ; Cao D; Lepor N; Mehran R
    J Am Heart Assoc; 2020 Dec; 9(24):e018897. PubMed ID: 33289416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dyslipidemia in acute coronary syndrome.
    Yadav S; Sawhney JPS
    Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S51-S57. PubMed ID: 38307382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III.
    Alanezi M; Yan AT; Tan MK; Bourgeois R; Malek-Marzban P; Beharry R; Alkurtass S; Gyenes GT; Nadeau PL; Nwadiaro N; Jedrzkiewicz S; Gao D; Chandna H; Nelson WB; Goodman SG;
    Cardiology; 2024; 149(3):266-274. PubMed ID: 38290490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Lowering Drugs in Acute Coronary Syndromes (ACS).
    Arnold N; Koenig W
    Curr Atheroscler Rep; 2023 Dec; 25(12):939-946. PubMed ID: 38015336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J.
    Nakamura M; Ako J; Arai H; Hirayama A; Nohara A; Murakami Y; Ozaki A; Harada-Shiba M
    J Atheroscler Thromb; 2021 Dec; 28(12):1307-1322. PubMed ID: 33612707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel.
    Haskiah F; Khaskia A
    J Clin Lipidol; 2023; 17(3):367-375. PubMed ID: 37120357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention.
    Marquis-Gravel G; Bhatia S; Brown V; Goodman SG
    Can J Cardiol; 2024 Aug; 40(8S):S35-S42. PubMed ID: 39111898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-Derived Biomarkers as Therapeutic Targets for Chronic Coronary Syndrome and Ischemic Stroke: An Updated Narrative Review.
    Schreiner TG; Ignat BE; Grosu C; Costache AD; Leon MM; Mitu F
    Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increasing importance of lipid lowering therapies as a part of the 'first medical contact' in patients with acute coronary syndrome.
    Akşit E; Küçük U; Kırılmaz B
    Int J Cardiol; 2024 Jul; 406():132095. PubMed ID: 38663804
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid Lowering Drugs: Present Status and Future Developments.
    Ruscica M; Ferri N; Santos RD; Sirtori CR; Corsini A
    Curr Atheroscler Rep; 2021 Mar; 23(5):17. PubMed ID: 33694108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline recommendations, clinical trial data, and new and emerging therapies.
    Lindsley J
    Am J Manag Care; 2021 Mar; 27(4 Suppl):S70-S75. PubMed ID: 33710846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.
    Nurmohamed NS; Navar AM; Kastelein JJP
    J Am Coll Cardiol; 2021 Mar; 77(12):1564-1575. PubMed ID: 33766264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existing and emerging therapies for the treatment of familial hypercholesterolemia.
    Rosenson RS
    J Lipid Res; 2021; 62():100060. PubMed ID: 33716107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bempedoic Acid: a cholesterol lowering agent with a novel mechanism of action.
    Nguyen H; Akamnonu I; Yang T
    Expert Rev Clin Pharmacol; 2021 May; 14(5):545-551. PubMed ID: 33691561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study.
    Kuo TT; Huang YB; Hsieh CJ
    BMJ Open; 2020 Nov; 10(11):e036769. PubMed ID: 33444173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art.
    Iannuzzo G; Gentile M; Bresciani A; Mallardo V; Di Lorenzo A; Merone P; Cuomo G; Pacileo M; Sarullo FM; Venturini E; D'Andrea A; Vigorito C; Giallauria F
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33916362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia: effective disease management with a focus on PCSK9 inhibitors.
    Shaw PB
    Am J Manag Care; 2021 Mar; 27(4 Suppl):S63-S69. PubMed ID: 33710845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients.
    Schiele F; Quignot N; Khachatryan A; Gusto G; Villa G; Kahangire D; Chauny JV; Ricci L; Desamericq G
    Int J Cardiol; 2021 Jun; 332():22-28. PubMed ID: 33705845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive effects associated with proprotein convertase subtilisin-kexin type 9 inhibitor use: a narrative review.
    Yuet WC; Ebert D; Jann M
    Ther Adv Drug Saf; 2021; 12():2042098620959271. PubMed ID: 33763200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia.
    Climent E; Marco-Benedí V; Benaiges D; Pintó X; Suárez-Tembra M; Plana N; Lafuente H; Ortega-Martínez de Victoria E; Brea-Hernando Á; Vila À; Civeira F; Pedro-Botet J
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1594-1603. PubMed ID: 33744038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.